Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
4.400
+0.100 (2.33%)
At close: Jul 14, 2026, 4:00 PM EDT
4.350
-0.050 (-1.14%)
Pre-market: Jul 15, 2026, 4:19 AM EDT
Inventiva Employees
As of December 31, 2025, Inventiva had 77 total employees, including 69 full-time and 8 part-time employees. The number of employees decreased by 41 or -34.75% compared to the previous year.
Employees
77
Change
-41
Growth
-34.75%
Revenue / Employee
$103,094
Profits / Employee
-$5,400,017
Market Cap
1.03B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 77 | -41 | -34.75% | 69 | 8 |
| Jun 30, 2025 | 84 | - | - | 84 | 0 |
| Dec 31, 2024 | 118 | -5 | -4.07% | 114 | 4 |
| Dec 31, 2023 | 123 | 10 | 8.85% | 120 | 3 |
| Dec 31, 2022 | 113 | 8 | 7.62% | 109 | 4 |
| Dec 31, 2021 | 105 | 11 | 11.70% | 101 | 4 |
| Mar 31, 2021 | 95 | 7 | 7.95% | 95 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| Kura Oncology | 260 |
| DBV Technologies | 161 |
| Olema Pharmaceuticals | 137 |
| Solid Biosciences | 121 |
| Janux Therapeutics | 108 |
| Lexicon Pharmaceuticals | 81 |
| Vor Biopharma | 76 |
IVA News
- 5 days ago - Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants - GlobeNewsWire
- 12 days ago - Results of the Votes of the Combined Shareholders' General Meeting of June 30, 2026 - GlobeNewsWire
- 4 weeks ago - Claret Capital Partners participates in €130m financing for Inventiva - GlobeNewsWire
- 4 weeks ago - Claret Capital Partners participates in €130m financing for Inventiva to support Phase 3 development - GlobeNewsWire
- 4 weeks ago - Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing - GlobeNewsWire
- 5 weeks ago - Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents - GlobeNewsWire
- 5 weeks ago - Inventiva Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Inventia Resumes Trading Of Ordinary Shares On Euronext Paris - Nasdaq